Revenues also were lower in the period, slipping 5% to US$21.17 billion from US$22.25 billion.
The growth comes at a pivotal time, as Unilever prepares to spin off its ice cream division.
North America recorded strong momentum, with growth of almost 6%.
There was strong demand in China, especially for infant milk formula and medical nutrition products.
Growth in the Americas and APMEA regions supported Kerry’s first-half performance despite persistent macroeconomic challenges.